Profiles

Keywords
Last Name
Institution

Parameswaran Venugopal

Concepts (221)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Combined Chemotherapy Protocols
18
2021
405
1.990
Why?
Leukemia, Myeloid, Acute
5
2021
46
1.460
Why?
Lymphoma, Non-Hodgkin
8
2019
52
1.430
Why?
Arabinonucleosides
4
2021
7
1.190
Why?
Lymphoma, Large B-Cell, Diffuse
6
2019
40
1.150
Why?
Antibodies, Monoclonal
8
2011
301
1.110
Why?
Antibodies, Monoclonal, Murine-Derived
11
2017
48
0.920
Why?
Central Nervous System Neoplasms
2
2021
19
0.890
Why?
Adenine Nucleotides
2
2010
6
0.840
Why?
Antineoplastic Agents
4
2020
274
0.700
Why?
Burkitt Lymphoma
3
2021
13
0.680
Why?
Paraproteinemias
2
2019
5
0.660
Why?
Lymphoma
1
2017
56
0.650
Why?
Insulin-Like Growth Factor Binding Proteins
1
2015
15
0.590
Why?
Insulin-Like Growth Factor I
1
2015
60
0.570
Why?
Treatment Outcome
18
2021
3910
0.510
Why?
Adult
21
2021
9779
0.480
Why?
Cyclophosphamide
9
2021
62
0.470
Why?
Necrobiotic Xanthogranuloma
1
2011
1
0.470
Why?
Plasma Cells
1
2011
9
0.470
Why?
Mediastinum
1
2011
8
0.470
Why?
Lymphoma, Mantle-Cell
1
2011
12
0.450
Why?
Humans
40
2021
31481
0.450
Why?
Middle Aged
23
2021
11209
0.450
Why?
Aged
20
2021
10295
0.420
Why?
Doxorubicin
7
2021
83
0.420
Why?
Arsenicals
2
2007
9
0.410
Why?
Oxides
2
2007
15
0.410
Why?
Male
24
2021
17583
0.410
Why?
Cranial Irradiation
2
2007
18
0.410
Why?
Vincristine
7
2019
37
0.400
Why?
Prednisone
7
2019
75
0.380
Why?
Lymphohistiocytosis, Hemophagocytic
1
2008
7
0.370
Why?
Female
26
2021
18253
0.370
Why?
Cachexia
2
2019
15
0.360
Why?
Disease-Free Survival
7
2021
241
0.350
Why?
Kaplan-Meier Estimate
5
2021
230
0.340
Why?
Leukemia, Myelomonocytic, Acute
1
2007
1
0.340
Why?
Sarcoma, Myeloid
1
2007
4
0.340
Why?
Ear Neoplasms
1
2007
5
0.340
Why?
Aged, 80 and over
10
2021
5234
0.340
Why?
Recurrence
6
2020
389
0.320
Why?
Purpura, Thrombotic Thrombocytopenic
1
2006
9
0.320
Why?
Drug Administration Schedule
6
2019
257
0.300
Why?
Brain Neoplasms
2
2006
187
0.300
Why?
Combined Modality Therapy
4
2019
456
0.280
Why?
Immunotherapy
2
2008
74
0.280
Why?
Lymphomatoid Granulomatosis
1
2003
3
0.270
Why?
HIV Infections
2
2021
951
0.270
Why?
Prognosis
6
2021
1028
0.260
Why?
Lymphoma, B-Cell
3
2008
15
0.260
Why?
Proto-Oncogene Proteins c-myc
2
2021
26
0.250
Why?
Remission Induction
6
2015
119
0.240
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
3
2011
30
0.230
Why?
Drug Resistance, Neoplasm
3
2020
76
0.220
Why?
Thrombosis
1
2021
67
0.210
Why?
Benzylidene Compounds
1
2020
2
0.210
Why?
Azepines
1
2020
6
0.210
Why?
Multiple Myeloma
1
2020
37
0.200
Why?
Graft vs Host Disease
1
2020
55
0.200
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2012
18
0.200
Why?
Folic Acid Deficiency
1
2019
8
0.200
Why?
Phthalazines
1
2019
9
0.200
Why?
Respiratory Insufficiency
1
2020
48
0.200
Why?
Proto-Oncogene Proteins c-bcl-2
1
2019
32
0.190
Why?
Hematopoietic Stem Cell Transplantation
1
2020
116
0.190
Why?
Proportional Hazards Models
2
2017
390
0.190
Why?
Neutropenia
4
2012
26
0.190
Why?
Cytosine
2
2021
5
0.180
Why?
Piperazines
1
2019
99
0.180
Why?
Young Adult
4
2021
2277
0.180
Why?
Medical Oncology
1
2018
39
0.180
Why?
Neoplasm Recurrence, Local
3
2021
236
0.180
Why?
Immunity
1
2017
23
0.170
Why?
Kidney Diseases
1
2019
146
0.170
Why?
Cardiology
1
2018
102
0.170
Why?
Immunocompromised Host
1
2017
55
0.160
Why?
Stroke Volume
1
2016
64
0.160
Why?
Biopsy
2
2019
283
0.150
Why?
Registries
1
2017
214
0.150
Why?
Feasibility Studies
2
2019
281
0.150
Why?
Induction Chemotherapy
1
2015
14
0.150
Why?
Hematologic Neoplasms
1
2014
23
0.140
Why?
Myelodysplastic Syndromes
2
2004
42
0.130
Why?
Central Nervous System
2
2021
61
0.130
Why?
Leukopenia
2
2011
10
0.130
Why?
Lymphoma, Follicular
2
2011
10
0.130
Why?
Retrospective Studies
3
2019
3591
0.130
Why?
Transcription Factors
2
2004
180
0.120
Why?
Daunorubicin
2
2015
5
0.120
Why?
Hemoglobinuria, Paroxysmal
1
2012
7
0.120
Why?
Transcriptome
1
2012
87
0.120
Why?
DNA-Binding Proteins
2
2004
264
0.120
Why?
Agranulocytosis
1
2011
7
0.120
Why?
Yttrium Radioisotopes
1
2011
7
0.110
Why?
Lymphoma, B-Cell, Marginal Zone
1
2011
7
0.110
Why?
Diabetes Mellitus, Type 2
1
2014
224
0.110
Why?
Fatal Outcome
2
2008
75
0.110
Why?
Retreatment
1
2010
18
0.110
Why?
Obesity
1
2014
338
0.110
Why?
Salvage Therapy
1
2010
42
0.110
Why?
Cytokines
1
2012
364
0.110
Why?
Platelet Count
2
2007
25
0.100
Why?
Pilot Projects
1
2011
455
0.100
Why?
Infusions, Intravenous
2
2020
89
0.090
Why?
Tretinoin
1
2007
19
0.090
Why?
Weight Loss
2
2019
114
0.080
Why?
Injections, Spinal
1
2007
54
0.080
Why?
Lymphoproliferative Disorders
1
2006
20
0.080
Why?
Vascular Neoplasms
1
2006
4
0.080
Why?
Plasma Exchange
1
2006
20
0.080
Why?
Tomography, X-Ray Computed
1
2011
891
0.080
Why?
ADAM Proteins
1
2006
95
0.070
Why?
Follow-Up Studies
1
2011
2028
0.070
Why?
Hemoglobins
1
2006
81
0.070
Why?
Twins, Dizygotic
1
2005
4
0.070
Why?
Autoantibodies
1
2006
119
0.070
Why?
Severity of Illness Index
2
2021
1240
0.070
Why?
Proto-Oncogenes
1
2004
5
0.070
Why?
Survival Analysis
2
2019
379
0.070
Why?
Thalidomide
1
2004
9
0.070
Why?
Radiography
1
2007
717
0.070
Why?
Kidney Transplantation
1
2006
141
0.070
Why?
Etoposide
2
2019
64
0.070
Why?
Peripheral Blood Stem Cell Transplantation
1
2004
7
0.070
Why?
Cohort Studies
2
2021
2014
0.070
Why?
Antigens, CD20
1
2003
8
0.070
Why?
Epilepsy, Tonic-Clonic
1
2003
9
0.070
Why?
Herpesvirus 4, Human
1
2003
17
0.070
Why?
Vision Disorders
1
2003
26
0.070
Why?
Epstein-Barr Virus Infections
1
2003
19
0.070
Why?
Cyclin D1
1
2003
5
0.070
Why?
Antigens, Neoplasm
1
2003
53
0.070
Why?
Cell Cycle Proteins
1
2003
15
0.070
Why?
K562 Cells
1
2003
7
0.070
Why?
Telomerase
1
2003
11
0.070
Why?
United States
2
2021
2539
0.070
Why?
Methotrexate
1
2003
47
0.070
Why?
Histones
1
2003
32
0.060
Why?
Cytarabine
2
2015
12
0.060
Why?
Azacitidine
1
2021
14
0.060
Why?
Apoptosis
1
2003
292
0.060
Why?
Cerebral Cortex
1
2003
206
0.060
Why?
L-Lactate Dehydrogenase
1
2021
9
0.060
Why?
Gene Rearrangement
1
2021
16
0.060
Why?
Risk Factors
2
2005
2664
0.050
Why?
Thrombocytopenia
2
2012
32
0.050
Why?
Folic Acid
1
2019
24
0.050
Why?
Monoclonal Gammopathy of Undetermined Significance
1
2019
2
0.050
Why?
Maintenance Chemotherapy
1
2019
4
0.050
Why?
Kidney Function Tests
1
2019
29
0.050
Why?
Immunoglobulin A
1
2019
18
0.050
Why?
Maximum Tolerated Dose
1
2019
20
0.050
Why?
Translocation, Genetic
1
2019
13
0.050
Why?
Symptom Assessment
1
2019
24
0.050
Why?
Vidarabine
2
2011
11
0.050
Why?
Anemia
2
2012
94
0.050
Why?
Transplantation, Homologous
1
2020
292
0.050
Why?
Sarcopenia
1
2019
34
0.050
Why?
Mitoxantrone
2
2011
6
0.050
Why?
Postoperative Complications
1
2006
1083
0.050
Why?
Body Composition
1
2019
81
0.050
Why?
Interdisciplinary Communication
1
2018
31
0.050
Why?
Ovarian Neoplasms
1
2019
82
0.040
Why?
Magnetic Resonance Imaging
1
2003
1273
0.040
Why?
Disease Management
1
2019
147
0.040
Why?
Lung Neoplasms
1
2003
756
0.040
Why?
Sex Factors
1
2019
542
0.040
Why?
Tomography, Emission-Computed
2
2006
13
0.040
Why?
Prospective Studies
2
2015
1934
0.040
Why?
Recombinant Proteins
2
2008
295
0.040
Why?
Neoplasms
1
2019
280
0.040
Why?
Disease Progression
2
2012
861
0.040
Why?
Naphthalimides
1
2015
2
0.040
Why?
Adenine
1
2015
7
0.040
Why?
Organophosphonates
1
2015
6
0.040
Why?
Lipid Metabolism
1
2014
50
0.040
Why?
Sensitivity and Specificity
2
2006
580
0.040
Why?
Insulin Resistance
1
2014
71
0.030
Why?
Adolescent
1
2021
2667
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2004
191
0.030
Why?
Cytogenetic Analysis
1
2012
7
0.030
Why?
Administration, Oral
1
2012
164
0.030
Why?
RNA, Messenger
2
2003
371
0.030
Why?
Pneumonia
1
2012
74
0.030
Why?
Signal Transduction
1
2014
588
0.030
Why?
Radiopharmaceuticals
1
2011
63
0.030
Why?
Time Factors
1
2015
1902
0.020
Why?
Nausea
1
2007
25
0.020
Why?
Methylprednisolone
1
2007
26
0.020
Why?
Creatinine
1
2007
59
0.020
Why?
Cisplatin
1
2007
107
0.020
Why?
Dose-Response Relationship, Drug
1
2006
512
0.020
Why?
Zinc Fingers
1
2004
10
0.020
Why?
Cell Lineage
1
2004
34
0.020
Why?
Spleen
1
2004
54
0.020
Why?
Teniposide
1
2004
2
0.020
Why?
Bleomycin
1
2004
4
0.020
Why?
Animals
1
2014
5312
0.020
Why?
E2F1 Transcription Factor
1
2003
3
0.020
Why?
S Phase
1
2003
12
0.020
Why?
E2F Transcription Factors
1
2003
5
0.020
Why?
Retinoblastoma Protein
1
2003
7
0.020
Why?
Drug Therapy, Combination
1
2004
265
0.020
Why?
Interferon-alpha
1
2004
71
0.020
Why?
Karyotyping
1
2003
14
0.020
Why?
Transplantation, Autologous
1
2004
223
0.020
Why?
DNA Primers
1
2003
64
0.020
Why?
Granulocytes
1
2003
25
0.020
Why?
Neoplasm Staging
1
2005
481
0.020
Why?
In Situ Hybridization, Fluorescence
1
2003
42
0.020
Why?
Bone Marrow Cells
1
2003
63
0.020
Why?
Cell Nucleus
1
2003
90
0.020
Why?
Patient Selection
1
2005
264
0.020
Why?
Transcription, Genetic
1
2003
125
0.020
Why?
Immunosuppressive Agents
1
2004
163
0.020
Why?
Blotting, Western
1
2003
225
0.020
Why?
Bone Marrow
1
2003
68
0.020
Why?
Polymerase Chain Reaction
1
2003
188
0.020
Why?
Acute Disease
1
2003
254
0.020
Why?
Immunohistochemistry
1
2003
494
0.010
Why?
Venugopal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description